Electricity meets ultrasound: a smarter way to target nerves?
NCT ID NCT06620471
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study explores whether measuring electrical impedance (tissue resistance) during ultrasound-guided nerve blocks can help doctors identify different tissues—like skin, fat, muscle, and nerves—more precisely. Researchers will test this in 100 adults receiving axillary, popliteal, or interscalene nerve blocks. The goal is to improve needle placement, boost block success, and reduce complications such as accidental injection into a nerve or blood vessel.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors place nerve block needles more accurately, potentially increasing success rates and lowering risks like nerve damage.
- What could go wrong
- This is an early observational study with only 100 participants, so results may not apply to all patients or settings. It measures tissue properties, not direct patient outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2024
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Community sample
- Ages
-
18 to 90 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Individuals aged 18 years to 90 years old * No infection at the injection site * Patient signed the study consent form * No contraindications for nerve block * No allergies to any of the drugs used * Patient able to communicate effectively Exclusion Criteria: * Patients not meeting the inclusion criteria * Patients with bleeding disorders or undergoing anticoagulation therapy * Pregnant patients * Patients with mental incapacity * Any medical conditions posing severe risks during the procedure
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Axillary nerve block are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Lebanese American University Rizk Hospital
RECRUITINGBeirut, Beirut, Lebanon
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a 48-Hour nerve block prevent the 'Rebound Pain' after shoulder surgery?
- New pain block may cut opioid use after shoulder surgery
- New painkiller could cut opioid use after shoulder surgery
- New study aims to decode which lung test best predicts breathing relief
- Which anesthesia gives surgeons a better view during shoulder surgery?
- New pain block method could improve shoulder surgery recovery